Get started
Author

R. Abdel Tawab

Observed names: R Abdel Tawab, Rasha Abdel Tawab, Rasha Tawab
OpenAlex ID: A5113946365
The Landscape of Cutaneous T-Cell Lymphoma (CTCL) in the Middle East and North Africa (MENA) and the Establishment of the MENA CTCL Working Group
2024 · Rasha Abdel Tawab, Jihan Rajy, et al. · Cancers · 3
PDF
PIG-C and SOCS3: Potential immunotargets regulated by non-coding RNAs in TNBC
2018 · M.M. Armanios, R. Abdel Tawab, et al. · Annals of Oncology · 2
88P CXCR2 small molecule antagonists: A novel approach to enhance the effect of PDL-1 inhibitors in triple-negative breast cancer
2021 · A. Ghallab, R. Abdel Tawab, et al. · Annals of Oncology · 1
Differential expression of PD-L1, MALAT1 and XIST in tumors and lymph nodes of TNBC and IDC patients and their regulation by miR-182
2017 · A. Samir, R Abdel Tawab, et al. · Annals of Oncology · 1
Outcome of Acute Myeloid Leukemia in Adults Treated with Standard Chemotherapy-a Single Center Retrospective Study
2023 · Abdul Rashid Shah, Mohan Ram, et al. · Blood
87P Epigenetics of the epigenetics: Impact of Let-7a expression restoration in CD8+ cells of HER2+ breast cancer patients
2021 · T. Monier, A. Samir, et al. · Annals of Oncology
XIST and TSIX: Novel cancer-immune biomarkers showing differential expression in tumor, PBMCs, serum, nipple discharge and lymph nodes of PD-L1 overexpressing BC patients
2017 · E. Atef, R. Abdel Tawab, et al. · Annals of Oncology
PDF
PO46 Sustained remission after mTOR inhibitor in a case of refractory HD
2012 · H. Abdel Azim, R. Abdel Tawab, et al. · Critical Reviews in Oncology/Hematology
Works count: 8
Citation count: 7
H-index: 2
I10-index:
Year
Topic
Type